Mapping systemic lupus erythematosus heterogeneity at the single-cell level.

TitleMapping systemic lupus erythematosus heterogeneity at the single-cell level.
Publication TypeJournal Article
Year of Publication2020
AuthorsNehar-Belaid D, Hong S, Marches R, Chen G, Bolisetty M, Baisch J, Walters L, Punaro M, Rossi RJ, Chung C-H, Huynh RP, Singh P, Flynn WF, Tabanor-Gayle J-A, Kuchipudi N, Mejias A, Collet MA, Lucido ALisa, Palucka K, Robson P, Lakshminarayanan S, Ramilo O, Wright T, Pascual V, Banchereau JF
JournalNat Immunol
Date Published2020 Aug 03
ISSN1529-2916
Abstract

Patients with systemic lupus erythematosus (SLE) display a complex blood transcriptome whose cellular origin is poorly resolved. Using single-cell RNA sequencing, we profiled ~276,000 peripheral blood mononuclear cells from 33 children with SLE with different degrees of disease activity and 11 matched controls. Increased expression of interferon-stimulated genes (ISGs) distinguished cells from children with SLE from healthy control cells. The high ISG expression signature (ISG) derived from a small number of transcriptionally defined subpopulations within major cell types, including monocytes, CD4 and CD8 T cells, natural killer cells, conventional and plasmacytoid dendritic cells, B cells and especially plasma cells. Expansion of unique subpopulations enriched in ISGs and/or in monogenic lupus-associated genes classified patients with the highest disease activity. Profiling of ~82,000 single peripheral blood mononuclear cells from adults with SLE confirmed the expansion of similar subpopulations in patients with the highest disease activity. This study lays the groundwork for resolving the origin of the SLE transcriptional signatures and the disease heterogeneity towards precision medicine applications.

DOI10.1038/s41590-020-0743-0
Custom 1

https://www.ncbi.nlm.nih.gov/pubmed/32747814?dopt=Abstract

Alternate JournalNat. Immunol.
PubMed ID32747814
Grant ListCORT P50AR070594 / / U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) /
CORT P50AR070594 / / U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) /
CORT P50AR070594 / / U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) /
CORT P50AR070594 / / U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) /
CORT P50AR070594 / / U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) /

Weill Cornell Medicine Gale and Ira Drukier Institute for Children's Health 413 E. 69th Street New York, NY 10021